Meet our senior team
Nawab Qizilbash, MD MSc DPhil
Chief Medical Officer & Head of OXON Epidemiology
Senior Clinical Epidemiologist and:
– Honorary Associate Professor, London School of Hygiene and Tropical Medicine, London University
– Honorary Consultant Geriatrician, Hospital Cantoblanco, Madrid
– Member of Green Templeton College, Oxford University
– Chief editor of ‘Evidence-based Dementia Practice’ published by Blackwells, Oxford.
Dr. Qizilbash has co-authored multiple high-impact publications, including articles in The Lancet (8), JAMA (1), and BMJ (3) covering topics in epidemiology, pragmatic trials, and meta-analysis.
Previously, he served as Director of Epidemiology and Evidence-based Medicine at GlaxoSmithKline (1997–2005), training under and collaborating with Professor Sir Richard Peto, F.R.S. He was also the Founding Editor of the Cochrane Dementia Group.
He completed his medical training in internal medicine and geriatrics under Professor Sir John Grimley Evans, with honorary consultant physician roles at the Radcliffe Infirmary, Oxford (1997–2000), and St Mary’s Hospital, London (2005–2006).
Among CROs in Europe, Dr. Qizilbash provides clients with a unique combination of high-quality epidemiological and clinical expertise across a wide range of therapeutic areas.
Steve Albrecht, BSc
Director of Global Strategic Development
Steve Albrecht, has over 30 years of operational experience directing observational studies, including compassionate use. He was most recently Global Head of Late Phase for Chiltern International, based in London, UK. He has been involved in directing over 150 observational studies, including large global registries and retrospective chart studies.
Lorenzo Domínguez, MD MPH
Director of Operations
Lorenzo is a medical doctor and epidemiologist with more than 20 years of experience in conducting observational studies in all major therapeutic areas in Europe. Lorenzo previously worked as an epidemiologist at AstraZeneca and the global CRO, SGS.
Ignacio Méndez, VMD MPH
Director of Data Analytics & HEORIgnacio has more than 19 years of experience in epidemiology, health economics, patient-reported outcomes and associated statistical methodologies.
He specialises in the application and analysis of PROs and health economic measures in observational studies, safety data, and benefit-risk and decision analysis. Ignacio has previously worked at the CRO, TAIS. He was a member of the ENCePP HTA task force of the EMA. He provides advanced statistical expertise.
Marta Mariño, BSc
Pharmacovigilance Director
Marta was previously head of pharmacovigilance at Schering-Plough from 1995-2010 and has experience of all areas and phases of drug safety. She has specialised in the operational, quality and compliance aspects of safety in observational studies and patient registries.
She ensures quality and compliance of all the quantitative safety projects in OXON.
Javier Scott-Glendonwyn, BSc MSc
Data Management & EDC Director
Javier coordinates the data management activities and the design and management of OXON’s Data Management System (DMS) comprising the electronic data capture tool (OXONeDC). He is responsible for building and managing the team, processes, policies, and structure and technology to deliver high quality data. He has over 20 years of experience in the Pharma industry, managing the development of Electronic Data Capture systems and project implementations. Furthermore, he has also worked in other technological areas such as health apps development and e-learning tools.
Janine de Haan, BSc MSc
Director of Operations & GPM
Janine is the Director of Operations at OXON and an experienced Global Project Manager with over a decade of experience in clinical research. She oversees project operations while managing global and European observational studies. Prior to joining OXON in 2019, Janine worked as a Research Nurse and Project Manager in phase II and III clinical trials and held project management roles at a global medical device company. She holds an MSc in Clinical Trial Management from Beuth University of Applied Sciences, Berlin, Germany.
Bélène Podmore, BSc MSc PhD
Director of Epidemiology
Bélène has a PhD in Clinical Epidemiology from the London School of Hygiene & Tropical Medicine (LSHTM) and a Master of Public Health from Imperial College London. Her PhD focused on the access to and outcomes of hip and knee replacement surgery for patients with chronic diseases using patient-reported and administrative databases. Before joining OXON, she was previously a Research Fellow at LSHTM investigating the impact of multimorbidity on surgical outcomes (continues as an Honorary Research Fellow). She also has been involved in implementing and evaluating healthcare interventions and new models of care through her position as a Project Manager at an Academic Health Science Centre. She also has experience of qualitative methods and systematic reviews from her PhD.
Alliances and Partnerships
OXON has established a range of strategic partnerships to enhance its capabilities in various areas of research and analysis.
Our expertise is further boosted by renowned Consultants (close collaborators on retainers) for involvement in projects as necessary
STATISTICS EXPERT
Stuart Pocock, MA PhD, Professor of Medical Statistics at the London School of Hygiene & Tropical Medicine, is an eminent medical statistician, a frequent lecturer on a variety of clinical trials issues and co-author of over 600 articles in peer-reviewed journals, (100+ NEJM/Lancet, and STROBE guideline) mainly in trials and epidemiology. He has an extensive experience with EMA/FDA and data monitoring (including Covid DISCOVERY adaptive platform trial) and devised: ´Pocock Stopping Rule´, ´Win Ratio´ and new method for ‘Individualising Benefit Risk’. Awarded the Bradford Hill Medal in 2013 by the Royal Statistical Society, Stuart has provided OXON with advice and validation of several complex analyses over the last 10 years.
AGREEMENTS AND COLLABORATIONS
– Agreement with two qualitative research companies to support cognitive testing and validation of questionnaires and additional risk minimisation materials in countries where they are developed by OXON.
– Close relationships with leading pharmaco-epidemiologists across key EU and Scandinavian countries to conduct multi-country database studies, including those related to pregnancy outcomes.
– Alliance with a major Health Maintenance Organization (HMO) in the USA to conduct database analyses in the US.
– Collaboration with a global health economics (HE) group to jointly perform economic modelling and develop Health Technology Assessment (HTA) dossiers.